Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a prescription digital therapeutics company focused on cardiometabolic diseases, including type 2 diabetes and hypertension, through behavioral medicine delivered via regulated software. The company completed its de-SPAC merger with Mountain Crest Acquisition Corp. II, sponsored by Mountain Crest Capital LLC, in 2021, bringing it to public markets in the healthcare technology sector. The October 2023 DEF 14A proxy filing reflects the company's ongoing post-merger public company obligations during a challenging period for the digital therapeutics industry broadly. For full filing history, investor data, and sponsor intelligence on BTTX and hundreds of other SPAC transactions, sign up for complete access at SpacDesk.